REVVITY, INC Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax
REVVITY, INC (RVTY) reported Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax of -$19.50 million for the 3-month period ending 2017-10-01, per its 10-Q filed 2017-11-07.
Discontinued › Notes
us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax · last filed 2017-11-07
- REVVITY, INC derivatives used in net investment hedge, increase (decrease), gross of tax for the quarter ending 2017-10-01 was -$19.50M, a 1183.33% decline year-over-year.
- REVVITY, INC derivatives used in net investment hedge, increase (decrease), gross of tax for the quarter ending 2017-07-02 was -$36.40M.
- REVVITY, INC derivatives used in net investment hedge, increase (decrease), gross of tax for the quarter ending 2017-04-02 was -$7.10M.
- REVVITY, INC derivatives used in net investment hedge, increase (decrease), gross of tax for the quarter ending 2017-01-01 was $12.00M.
- REVVITY, INC derivatives used in net investment hedge, increase (decrease), gross of tax for fiscal 2017 was $1.80M.
| Period end | Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax 3 month | Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax 6 month | Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax 9 month | Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax 12 month |
|---|---|---|---|---|
| 2017-10-01 | -$19.50M 10-Q · filed 2017-11-07 | -$55.90M derived: sum of 2 quarters · filed 2017-11-07 | -$63.10M 10-Q · filed 2017-11-07 | -$51.00M derived: sum of 4 quarters · filed 2017-11-07 |
| 2017-07-02 | -$36.40M 10-Q · filed 2017-08-08 | -$43.50M 10-Q · filed 2017-08-08 | -$31.50M derived: sum of 3 quarters · filed 2017-08-08 | -$29.70M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-04-02 | -$7.10M 10-Q · filed 2017-05-09 | $4.90M derived: sum of 2 quarters · filed 2017-05-09 | $6.70M derived: sum of 3 quarters · filed 2017-05-09 | |
| 2017-01-01 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $13.80M derived: sum of 2 quarters · filed 2017-02-28 | $1.80M 10-K · filed 2017-02-28 | |
| 2016-10-02 | $1.80M 10-Q · filed 2016-11-08 | -$10.20M 10-Q · filed 2016-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |